NASDAQ:ARNA
Delisted

Arena Pharmaceuticals Stock Forecast

etoro logo Buy ARNA
*Your capital is at risk
$99.99
+0 (+0%)
At Close: May 27, 2022

ARNA Performance

FAQ

What is the symbol for Arena Pharmaceuticals Stock and on which exchange is it traded?
The symbol for Arena Pharmaceuticals is ARNA and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Arena Pharmaceuticals Stock?
Arena Pharmaceuticals holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

How to buy Arena Pharmaceuticals Stock?
Arena Pharmaceuticals Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Arena Pharmaceuticals Stock.

What's the current price of Arena Pharmaceuticals Stock?
As of the end of day on the May 27, 2022, the price of an Arena Pharmaceuticals (ARNA) share was $99.99.

What is the 52-week high and low for Arena Pharmaceuticals Stock?
The 52-week high for Arena Pharmaceuticals Stock is $100.00 and the 52-week low is $45.50.
Click to get the best stock tips daily for free!
ABOUT ARENA PHARMACEUTICALS
Arena Pharmaceuticals
Arena Pharmaceuticals, Inc., a biopharmaceutical company, focuses on providing novel medicines with pharmacology and pharmacokinetics to patients worldwide. The company's investigational clinical programs include Etrasimod (APD334) that is in Phase III clinical trial for ulcerative colitis, Phase IIb/III clinical trial for Crohn's disease, Phase II clinical trial for alopecia areata, Phase III clinical trial for atopic dermatitis, and Phase IIb c...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
4.43% Jun 01
N
NVRI
$19.53
0.87% May 20
RUN
$12.83
15.51% May 06
GLBE
$31.61
4.05% May 05
SAP
$172.39
8.56% May 05

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE